Thư viện tri thức trực tuyến
Kho tài liệu với 50,000+ tài liệu học thuật
© 2023 Siêu thị PDF - Kho tài liệu học thuật hàng đầu Việt Nam

Kết quả điều trị hóa chất bằng phác đồ MP trên bệnh nhân đa u tủy xương cao tuổi tại khoa huyết học truyền máu - Bệnh viện Bạch Mai
Nội dung xem thử
Mô tả chi tiết
TCNCYH 71 (6J - 2010
5. Keeffe EB, DIetcrich DT, Han SHB, Gane E, Han KH, ct al (2008). Asian - Pacific
Jacobson IM, Martin P, Schiff ER, et Al (2008). A consensus statement on the management of
treatment algorithm for the management of chronic hepatitis B: a 2008 update. Ilepatollnt; ?.:
chronic hepatitis B virus infection in the United 263 - 283.
Slates; 2008 update. Clin Gastroenterol Hepatol; g_ Lok ASF, McMahon B| (2007). Chronic
6; 1315- 1 341. hepatitis B. HEPATOLOGY; 45; 507 - 539.
6. Lai C - L, Shouval D, Lok AS, et al (2006). g g^jfj.^ ;^ Hamatake RK, Colonno RJ,
Entecavir versus lamivudine for patients with standring DN (1998). In vitro inhibition of hepadHBeAg - negative chronic hepatitis B. N Engl J navims polymerase's by the triphosphates of BMSMed; 354; 1011 - 1020. 200475 and lobucavir. Antimicrob. Agents
7. Llaw YF, Leung N, Kao |H, PIratvisuth T, Chemother; 42; 3200 8.
Summary
HISTOLOGICAL CHANGES AFTER ONE YEAR OF ENTECAVIR TREATMENT
IN PATIENTS WITH CHRONIC HEPATITIS B
Objective: To evaluate histological changes in liver biopsy induced by 48 weeks of entecavir treatment
in adult chronic hepatitis B patients. Methods: we randomly assigned 47 chronic hepatitis' B virus, the
patients received 0,5mg entecavir once daily, in which sixteen patients had liver bio[)y t'or modified
Knodell score evaluation prelreatment and al week 48 of entecavir treatment. Results: Histologic
improvement at week 48 of entecavir treatment occurred in 62.5% patients. Necroimflammatory score
decreased from 10.8 ± 2.9 to 5.3 ± 2.4 (p < 0.0001). Mean fibrosis score showed a reduction in their
score from 3.19 ± 1.97 to 2.81 ± 2.07. The reduction of mean serum 1IBV - f5NA levels al week 48 was -
6.23 ± 1.68 logeopies/ml, HBeAg seroconversion occured in 15.9%. Conclusion: histological improvement
in liver biopsy achieved highly at week 48 of entecavir treatment in chronic hepatitis B patients.
Keywords: Chronic hepatitis B, Entecavir, liver biopsy
KET QUA DIEU TR[ HOA CHAT BANG PHAC DO MP TREN
BENH NHAN DA U TUY XadNG CAO TUOI TAI
KHOA HUYET HOC TRUYEN MAU - BENH VIEN B/\CH MAI
Vu Minh PhUPng, Pham Hong DUPng
Tnfdng Dai hoc Y I la Ndi
Muc tieu: (1) Nghien cdu mot so thay doi lam sang va xet nghiem d benh nhin da u tuy xifang cao ludi
sau dieu trj bang pbac do MP. F)di tugng va phuang phap nghien ctfu: 25 benh nhin d Khoa I luyet hoc -
truyen miu benh vien Bach Mai difac chin doin da u tuy xdang va diiu Iri phic do MP. Kdt qua: t'y le thieu
mau giam td 8S%o xudng 55%, sau dat dieu tri thd 3, ty le dau xUang giam td 80%, xudng 52%, sau dai dieu trj
thd 2, lib ting td 74,1 ± 29,7 g/l len 114,9 ± 19,7 g/l sau dat dieu trj thd 3, Protein miu toan phin. Globulin
va Ig benh ly, Creatinin deu giam sau cic dot diiu trj thd 3 va thd 4, ty le benh nhin cd can xi > 2,6 mmol/l